SIRT4 inhibits cigarette smoke extracts-induced mononuclear cell adhesion to human pulmonary microvascular endothelial cells via regulating NF-κB activity

Toxicology Letters

Volumn 226, Issue 3, 2014, Pages 320-327

  Chen, Yongfeng ^a   Wang, Haijing ^a   Luo, Guangming ^a   Dai, Xiaotian ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Chronic obstructive pulmonary disease; Cigarette smoke extract; Monocyte adhesion; NF B; SIRT4

Indexed keywords

CIGARETTE SMOKE; CIGARETTE SMOKE EXTRACT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; SIRTUIN 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL ADHESION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN PULMONARY MICROVASCULAR ENDOTHELIAL CELL; INFLAMMATION; MICROVASCULAR ENDOTHELIAL CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING; STRESS;

CHRONIC OBSTRUCTIVE PULMONARY DISEASE; CIGARETTE SMOKE EXTRACT; MONOCYTE ADHESION; NF-ΚB; SIRT4;

ADP RIBOSE TRANSFERASES; CELL ADHESION; CELLS, CULTURED; E-SELECTIN; ENDOTHELIAL CELLS; HUMANS; I-KAPPA B KINASE; LEUKOCYTES, MONONUCLEAR; MITOCHONDRIAL PROTEINS; NF-KAPPA B; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SIRTUINS; SMOKE; TOBACCO; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84897862589     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.02.022     Document Type: Article

References (47)

1. Ahuja N., Schwer B., Carobbio S., Waltregny D., North B.J., Castronovo V., Maechler P., Verdin E. Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. J. Biol. Chem. 2007, 282:33583-33592.
2. Anto R.J., Mukhopadhyay A., Shishodia S., Gairola C.G., Aggarwal B.B. Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2. Carcinogenesis 2002, 23:1511-1518.
3. Bhatt S.P., Dransfield M.T. Chronic obstructive pulmonary disease and cardiovascular disease. Transl. Res. 2013, 162:237-251.
4. Borradaile N.M., Pickering J.G. NAD(+), sirtuins, and cardiovascular disease. Curr. Pharm. Des. 2009, 15:110-117.
5. Brody H. Chronic obstructive pulmonary disease. Nature 2012, 489:S1.
6. Cardus A., Uryga A.K., Walters G., Erusalimsky J.D. SIRT6 protects human endothelial cells from DNA damage, telomere dysfunction, and senescence. Cardiovasc. Res. 2013, 97:571-579.
7. Carp H., Janoff A. Possible mechanisms of emphysema in smokers. In vitro suppression of serum elastase-inhibitory capacity by fresh cigarette smoke and its prevention by antioxidants. Am. Rev. Respir. Dis. 1978, 118:617-621.
8. Chen C.J., Fu Y.C., Yu W., Wang W. SIRT3 protects cardiomyocytes from oxidative stress-mediated cell death by activating NF-κB. Biochem. Biophys. Res. Commun. 2013, 430:798-803.
9. Chengye Z., Daixing Z., Qiang Z., Shusheng L. PGC-1-related coactivator (PRC) negatively regulates endothelial adhesion of monocytes via inhibition of NF κB activity. Biochem. Biophys. Res. Commun. 2013, 439:121-125.
10. Cogswell P.C., Kashatus D.F., Keifer J.A., Guttridge D.C., Reuther J.Y., Bristow C., Roy S., Nicholson D.W., Baldwin A.S. NF-κB and IκBα are found in the mitochondria, evidence for regulation of mitochondrial gene expression by NF-κB. J. Biol. Chem. 2003, 278:2963-2968.
11. Collins T., Cybulsky M.I. NF-kB: pivotal mediator or innocent bystander in 360 atherogenesis?. J. Clin. Invest. 2001, 107:255-264.
12. Garcia Soriano F., Virag L., Jagtap P., Szabo E., Mabley J.G., Liaudet L., et al. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat. Med. 2001, 7:108-113.
13. Haigis M.C., Mostoslavsky R., Haigis K.M., Fahie K., Christodoulou D.C., Murphy A.J., Valenzuela D.M., Yancopoulos G.D., Karow M., Blander G., Wolberger C., Prolla T.A., Weindruch R., Alt F.W., Guarente L. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 2006, 126:941-954.
14. Hassa P.O., Covic M., Hasan S., Imhof R., Hottiger M.O. The enzymatic and DNA binding activity of PARP-1 are not required for NF-kappa B coactivator function. J. Biol. Chem. 2001, 276:45588-45597.
15. Johnson R.F., Witzel I.I., Perkins N.D. p53-dependent regulation of mitochondrial energy production by the RelA subunit of NF-κB. Cancer Res. 2011, 71:5588-5597.
16. Kameoka M., Ota K., Tetsuka T., Tanaka Y., Itaya A., Okamoto T., Yoshihara K. Evidence for regulation of NF-kappaB by poly(ADP-ribose) polymerase. Biochem. J. 2000, 346:641-649.
17. Kawamura Y.I., Kawashima R., Shirai Y., Kato R., Hamabata T., Yamamoto M., Furukawa K., Fujihashi K., McGhee J.R., Hayashi H., Dohi T. Cholera toxin activates dendritic cells through dependence on GM1-ganglioside which is mediated by NF-kappaB translocation. Eur. J. Immunol. 2003, 33:3205-3212.
18. Kim K.J., Kim H.A., Seo K.H., Lee H.K., Kang B.Y., Im S.Y. Cholera toxin breakdowns oral tolerance via activation of canonical NF-κB. Cell. Immunol. 2013, 285:92-99.
19. Lappas M. Anti-inflammatory properties of sirtuin 6 in human umbilical vein endothelial cells. Mediat. Inflamm. 2012, 597514.
20. Ley K., Laudanna C., Cybulsky M.I., et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 2007, 7:678-689.
21. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
22. Lim R., Barker G., Lappas M. SIRT6 is decreased with preterm labor and regulates key terminal effector pathways of human labor in fetal membranes. Biol. Reprod. 2013, 88:17.
23. Liszt G., Ford E., Kurtev M., Guarente L. Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J. Biol. Chem. 2005, 280:21313-21320.
24. Liu X., Togo S., Al-Mugotir M., Kim H., Fang Q., Kobayashi T., Wang X., Mao L., Bitterman P., Rennard S. NF-kappa B mediates the survival of human bronchial epithelial cells exposed to cigarette smoke extract. Respir. Res. 2008, 9:66.
25. Liu B., Che W., Xue J., Zheng C., Tang K., Zhang J., Wen J., Xu Y. SIRT4 prevents hypoxia-induced apoptosis in H9c2 cardiomyoblast cells. Cell. Physiol. Biochem. 2013, 32:655-662.
26. Nasrin N., Wu X., Fortier E., Feng Y., Bare O.C., Chen S., Ren X., Wu Z., Streeper R.S., Bordone L. SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells. Sci. Signal. 2010, 285:31995-32002.
27. Petrusca D.N., Van Demark M., Gu Y., Justice M.J., Rogozea A., Hubbard W.C., Petrache I. Smoking exposure induces human lung endothelial cells adaptation to apoptotic stress. Am. J. Respir. Cell Mol. Biol. 2014, 50:513-525.
28. Pirinen E., Lo Sasso G., Auwerx J. Mitochondrial sirtuins and metabolic homeostasis. Best Pract. Res. Clin. Endocrinol. Metab. 2012, 26:759-770.
29. Rahman M.M., Laher I. Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms. Curr. Vasc. Pharmacol. 2007, 5:276-292.
30. Rajendrasozhan S., Yang S.R., Kinnula V.L., Rahman I. SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2008, 177:861-870.
31. Rius C., Company C., Piqueras L., Cerdá-Nicolás J.M., González C., Servera E., Ludwig A., Morcillo E.J., Sanz M.J. Critical role of fractalkine (CX3CL1) in cigarette smoke-induced mononuclear cell adhesion to the arterial endothelium. Thorax 2013, 68:177-186.
32. Rothgiesser K.M., Erener S., Waibel S., Lüscher B., Hottiger M.O. SIRT2 regulates NF-κB dependent gene expression through deacetylation of p65 Lys310. J. Cell Sci. 2010, 123:4251-4258.
33. Sauve A.A., Youn D.Y. Sirtuins NAD(+)-dependent deacetylase mechanism and regulation. Curr. Opin. Chem. Biol. 2012, 16:535-543.
34. Schlegel N., Leweke R., Meir M., Germer C.T., Waschke J. Role of NF-κB activation in LPS-induced endothelial barrier breakdown. Histochem. Cell Biol. 2012, 138:627-641.
35. Schweitzer K.S., Hatoum H., Brown M.B., Gupta M., Justice M.J., Beteck B., Van Demark M., Gu Y., Presson R.G., Hubbard W.C., Petrache I. Mechanisms of lung endothelial barrier disruption induced by cigarette smoke: role of oxidative stress and ceramides. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 301:L836-L846.
36. Shen Y., Rattan V., Sultana C., Kalra V.K. Cigarette smoke condensate-induced adhesion molecule expression and transendothelial migration of monocytes. Am. J. Physiol. 1996, 270:H1624-H1633.
37. Sheng B., Wang X., Su B., Lee H.G., Casadesus G., Perry G., Zhu X. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease. J. Neurochem. 2012, 120:419-429.
38. Shi H., Sheng B., Zhang F., Wu C., Zhang R., Zhu J., Xu K., Kuang Y., Jameson S.C., Lin Z., Wang Y., Chen J., Jain M.K., Atkins G.B. Kruppel-like factor 2 protects against ischemic stroke by regulating endothelial blood brain barrier function. Am. J. Physiol. Heart Circ. Physiol. 2013, 304:H796-H805.
39. Tang B.L. Sirt1's systemic protective roles and its promise as a target in antiaging medicine. Transl. Res. 2011, 157:276-284.
40. Verheugd P., Forst A.H., Milke L., Herzog N., Feijs K.L., Kremmer E., Kleine H., Lüscher B. Regulation of NF-κB signalling by the mono-ADP-ribosyltransferase ARTD10. Nat. Commun. 1683, 4(49).
41. Winnik S., Stein S., Matter C.M. SIRT1 - an anti-inflammatory pathway at the crossroads between metabolic disease and atherosclerosis. Curr. Vasc. Pharmacol. 2012, 10:693-696.
42. Yang S.R., Wright J., Bauter M., Seweryniak K., Kode A., Rahman I. Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am. J. Physiol. Lung Cell Mol. Physiol. 2007, 292:L567-L576.
43. Yang H., Zhang W., Pan H., Feldser H.G., Lainez E., Miller C., Leung S., Zhong Z., Zhao H., Sweitzer S., Considine T., Riera T., Suri V., White B., Ellis J.L., Vlasuk G.P., Loh C. SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-κB activity. PLOS ONE 2012, 7:e46364.
44. Yi B., Zeng J., Wang G., Qian G., Lu K. Annexin A1 protein regulates the expression of PMVEC cytoskeletal proteins in CBDL rat serum-induced pulmonary microvascular remodeling. J. Transl. Med. 2013, 11:98.
45. Zerfaoui M., Errami Y., Naura A.S., Suzuki Y., Kim H., Ju J., Liu T., Hans C.P., Kim J.G., Abd Elmageed Z.Y., Koochekpour S., Catling A., Boulares A.H. Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-kappa B upon TLR4 stimulation. J. Immunol. 2010, 185:1894-1902.
46. Zhou F., Zhang L., Gong K., Lu G., Sheng B., Wang A., Zhao N., Zhang X., Gong Y. LEF-1 activates the transcription of E2F1. Biochem. Biophys. Res. Commun. 2008, 365:149-153.
47. Zhou G., Hamik A., Nayak L., Tian H., Shi H., Lu Y., Sharma N., Liao X., Hale A., Boerboom L., Feaver R.E., Gao H., Desai A., Schmaier A., Gerson S.L., Wang Y., Atkins G.B., Blackman B.R., Simon D.I., Jain M.K. Endothelial Kruppel-like factor 4 protects against atherothrombosis in mice. J. Clin. Invest. 2012, 122:4727-4731.